Jamie Dunn graduated from the University of Manchester with a degree in Pharmacology and has been a member of the company since November 2014. He was then subsequently awarded an MSc in Toxicology from the University of Birmingham in 2019, after 2 years of part-time study and weekly travel between Oxfordshire and Birmingham, and with the professional and financial support of Penman Consulting.
He has been active in many projects within the company, focusing primarily on substance identity and mammalian testing strategies for complex UVCB registrations under REACH. Ongoing work on these testing strategies is designed to reduce the overall burden of testing requirements whilst remaining scientifically robust.
Additionally, Jamie is proficient in using ECHA’s IUCLID software for the reporting and submission of scientific data to regulatory authorities, and in this capacity has also worked with DEFRA as they begin to develop the UK’s equivalent to REACH.